Wockhardt - World class Contract Manufacturing Organisation
 Home
 About Contract Manufacturing
 Our Know How
 Our Facilities
 
Wockhardt - UK
Pinewood - Ireland
Negma Laboratories - France
Morton Grove - USA
Baddi, Himachal Pradesh
Biotech Park (Formulation I & II)
Waluj Cephalosporins
Chikalthana L-1
EoU, Waluj (Oral Solid Division)
Daman, Bhimpore
Daman, Kadaiya
SEZ, Shendra
 Our News
 Contact Us
The Wockhardt Advantage

Chikalthana L-1

OVERVIEW

Established in the year:1979
Facility Area: 24,000 m2
Formulation mfg area: 12,000 m2
API manufacturing area: 1,709 m2
Dosage form: Tablets
Capsules
Powder & dry suspensions
Sterile injectables (ampoules & vials)
Regulatory approval:USFDA / MHRA

Wockhardt's Chikalthana facility, India, is one of our oldest and most established facilities within our network, which offers full commercial manufacturing services for conventional solid and sterile liquid forms. With our aseptic liquids capacity we can offer a range of sizes for glass vials and ampoules. The facilities solid dose capabilities include standard, sugar and film coated tablets whilst also offering hard gelatine capsules that are packed in blister or bottle formats. Chikalthana is also able to offer powder and dry suspension capacity into bottles and also boasts API manufacturing capabilities.

Qualified Persons are able to release product, for European and US markets, through our Wockhardt UK facility.

 

   Copyright © 2008. Wockhardt. All Rights Reserved.Sitemap  |  www.wockhardt.com
   Website Design by Global Solutions